Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Gefunden in
Schlagwort
- business 18 Treffer
- business.industry 18 Treffer
- hemic and lymphatic diseases 18 Treffer
- humans 18 Treffer
- leukemia, myelogenous, chronic, bcr-abl positive 16 Treffer
-
45 weitere Werte:
- medicine.drug 16 Treffer
- general medicine 14 Treffer
- imatinib mesylate 14 Treffer
- imatinib 13 Treffer
- myeloid leukemia 12 Treffer
- pyrimidines 12 Treffer
- medicine.medical_specialty 11 Treffer
- benzamides 10 Treffer
- internal medicine 10 Treffer
- neoplasms 10 Treffer
- pharmacology 10 Treffer
- piperazines 10 Treffer
- cancer research 9 Treffer
- dasatinib 9 Treffer
- drug resistance, neoplasm 9 Treffer
- leukemia 9 Treffer
- medicine.drug_class 9 Treffer
- pharmacology (medical) 9 Treffer
- protein kinase inhibitors 9 Treffer
- tyrosine-kinase inhibitor 9 Treffer
- antineoplastic agents 8 Treffer
- oncology 8 Treffer
- immunology 7 Treffer
- middle aged 7 Treffer
- tyrosine kinase 7 Treffer
- chronic myelogenous leukemia 6 Treffer
- female 6 Treffer
- male 6 Treffer
- thiazoles 6 Treffer
- aged 5 Treffer
- myelogenous 5 Treffer
- philadelphia chromosome 5 Treffer
- retrospective studies 5 Treffer
- adult 4 Treffer
- animals 4 Treffer
- medicine.medical_treatment 4 Treffer
- nilotinib 4 Treffer
- protein-tyrosine kinases 4 Treffer
- aged, 80 and over 3 Treffer
- biology 3 Treffer
- cancer 3 Treffer
- chemistry 3 Treffer
- health policy 3 Treffer
- in patient 3 Treffer
- respiratory tract diseases 3 Treffer
Publikation
Sprache
21 Treffer
-
In: Expert Opinion on Investigational Drugs, Jg. 20 (2011-11-18), S. 1583-1589Online unknownZugriff:
-
In: Journal of Medical Economics, Jg. 19 (2015-12-22), S. 445-461Online unknownZugriff:
-
In: Expert Opinion on Therapeutic Patents, Jg. 24 (2014-08-27), S. 1117-1127Online unknownZugriff:
-
In: Expert Opinion on Biological Therapy, Jg. 14 (2014-01-03), S. 287-299Online unknownZugriff:
-
In: Journal of Medical Economics, Jg. 17 (2013-11-26), S. 89-98Online unknownZugriff:
-
In: Current Medical Research and Opinion, Jg. 30 (2013-11-21), S. 529-536Online unknownZugriff:
-
In: Expert Opinion on Pharmacotherapy, Jg. 13 (2012-09-20), S. 2381-2395Online unknownZugriff:
-
In: Current Medical Research and Opinion, Jg. 28 (2012-06-28), S. 1155-1162Online unknownZugriff:
-
In: Current Medical Research and Opinion, Jg. 28 (2012-01-09), S. 213-219Online unknownZugriff:
-
In: Expert Opinion on Drug Safety, Jg. 10 (2010-12-02), S. 97-107Online unknownZugriff:
-
In: Current Medical Research and Opinion, Jg. 26 (2010-11-09), S. 2861-2869Online unknownZugriff:
-
In: Expert Opinion on Pharmacotherapy, Jg. 15 (2013-10-23), S. 1-3Online unknownZugriff:
-
In: Current Medical Research and Opinion, Jg. 26 (2009-11-11), S. 61-69Online unknownZugriff:
-
In: Journal of Medical Economics, Jg. 12 (2009), S. 164-169Online unknownZugriff:
-
In: Leukemia & Lymphoma, Jg. 49 (2008), Heft 1, S. 19-26Online unknownZugriff:
-
In: Expert Opinion on Pharmacotherapy, Jg. 8 (2007-11-26), S. 3257-3264Online unknownZugriff:
-
In: Expert Opinion on Investigational Drugs, Jg. 14 (2005-07-29), S. 1063-1066Online unknownZugriff:
-
In: Expert Opinion on Investigational Drugs, Jg. 14 (2005), S. 89-91Online unknownZugriff:
-
In: Expert Opinion on Investigational Drugs, Jg. 20 (2011-01-16), S. 137-140Online unknownZugriff:
-
In: Expert Opinion on Emerging Drugs, Jg. 6 (2001-10-01), S. 303-315Online unknownZugriff: